Paper971945
Lysis of Acholeplasma laidlawii by antibodies and complement.
Brunner H and 4 others. Infect Immun, 1976. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Lysis of Acholeplasma laidlawii by antibodies and complement. Papers, record 971945. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/971945
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acholeplasma laidlawii | Major topic |
| Antibodies, Bacterial | Major topic |
| Complement System Proteins | Major topic |
| Acholeplasma | |
| Cell Membrane | |
| Microscopy, Electron |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13,851,485 | Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes. | J Exp Med | 1959 | https://conductscience.org/library/papers/13851485 | PubMed |
| 2 | 13,878,126 | Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. | Proc Natl Acad Sci U S A | 1962 | https://conductscience.org/library/papers/13878126 | PubMed |
| 4 | 61,175 | Complement-mediated killing of Acholeplasma laidlawii by antibodies to various membrane components. | Infect Immun | 1976 | https://conductscience.org/library/papers/61175 | PubMed |
| 5 | 4,174,135 | Chemistry and reaction mechanisms of complement. | Adv Immunol | 1968 | https://conductscience.org/library/papers/4174135 | PubMed |
| 6 | 4,117,012 | Mechanism of cytolysis by complement. | Proc Natl Acad Sci U S A | 1972 | https://conductscience.org/library/papers/4117012 | PubMed |
| 7 | 4,346,598 | Studies on the terminal stages of complement lysis. | Immunology | 1973 | https://conductscience.org/library/papers/4346598 | PubMed |
| 8 | 4,572,613 | Ultrastructural lesions in Mycoplasma pneumoniae membranes produced by antibody and complement. | Infect Immun | 1973 | https://conductscience.org/library/papers/4572613 | PubMed |
| 9 | 4,554,562 | Antibody-complement interaction with lipid model membranes. | Biochim Biophys Acta | 1972 | https://conductscience.org/library/papers/4554562 | PubMed |
| 10 | 5,058,233 | Molecular analysis of the membrane attack mechanism of complement. | J Exp Med | 1972 | https://conductscience.org/library/papers/5058233 | PubMed |
| 11 | 4,908,393 | The lesions in cell membranes caused by complement. | Adv Immunol | 1969 | https://conductscience.org/library/papers/4908393 | PubMed |
| 12 | 5,332,190 | Interaction of polyene antibiotics with natural and artificial membrane systems. | Fed Proc | 1966 | https://conductscience.org/library/papers/5332190 | PubMed |
| 13 | 5,246,926 | Immune response of a liposomal model membrane. | Proc Natl Acad Sci U S A | 1968 | https://conductscience.org/library/papers/5246926 | PubMed |
| 14 | 5,539,640 | Production of ultrastructural membrane lesions by the fifth component of complement. | J Exp Med | 1971 | https://conductscience.org/library/papers/5539640 | PubMed |
| 15 | 5,482,273 | Fate of phospholipids in liposomal model membranes damaged by antibody and complement. | Biochemistry | 1970 | https://conductscience.org/library/papers/5482273 | PubMed |
| 16 | 5,417,177 | The relationship between fatty acid structure and the positional distribution of esterified fatty acids in phosphatidyl glycerol from Mycoplasma laidlawii B. | Biochim Biophys Acta | 1970 | https://conductscience.org/library/papers/5417177 | PubMed |
| 17 | 5,795,461 | Immunochemical analysis of Mycoplasma pneumoniae. 3. Separation and chemical identification of serologically active lipids. | Aust J Exp Biol Med Sci | 1969 | https://conductscience.org/library/papers/5795461 | PubMed |
| 18 | 5,777,213 | Mycoplasma membrane lipids: variations in fatty acid composition. | Science | 1969 | https://conductscience.org/library/papers/5777213 | PubMed |
| 19 | 5,643,073 | Serum complement and the enzymatic degradation of erythrocyte phospholipid. | J Immunol | 1968 | https://conductscience.org/library/papers/5643073 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,249,263 | Complement-mediated production of plasma-membrane vesicles from rat fat-cells. | Biochem J | 1980 | https://conductscience.org/library/papers/6249263 | PubMed |
| 908,614 | Antibodies to Acholeplasma laidlawii membrane lipids in normal guinea pig serum. | Infect Immun | 1977 | https://conductscience.org/library/papers/908614 | PubMed |
| 641,139 | Increased fluidity of human platelet membranes during complement-mediated immune platelet injury. | J Clin Invest | 1978 | https://conductscience.org/library/papers/641139 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/971945
GET https://conductscience.org/api/papers/v1/971945/authors